Florida Pharma Distributor Involved in Illegal Blood Diversion Scheme

Drug Industry Daily
KEYWORDS courts / FDA
A A

A father-and-son team involved in an illegal scheme to divert pharmaceutical products were convicted on 247 criminal counts, including wire fraud, money laundering, conspiracy and racketeering, the FDA’s Office of Criminal Investigation (OCI) announced April 18.

To View This Article:

Login

Subscribe To Drug Industry Daily